Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phosphate in Acute Pancreatitis (PPP)
NCT07681050Phase 2Recruiting
- Sponsor
- Duke University
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial of sodium phosphate and potassium phosphate in acute pancreatitis (AP) (2 arms), sponsored by Duke University. Primary endpoints: Serum Phosphorus Levels up to 7 days and Disease Severity as measured by the Revised Atlanta Classification (RAC) up to 7 days. Started Jul 2026; status: recruiting.
02
Drugs
sodium phosphatepotassium phosphate
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT07681050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07681050.